Answer
Targinact is indicated as second-line symptomatic treatment for adults with severe to very severe idiopathic restless legs syndrome after failure of dopaminergic therapy.
Sources for this answer
- Targinact 40 mg / 20 mg prolonged release tabletsNapp Pharmaceuticals Limited · emc · SmPC §4.1 Therapeutic Indications · Version 8Document updated
Sources checked